Cannabis Report
Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

Aspire made it possible for the company to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
KarinCA Member Profile
Member Level 
Followed By 532
Posts 23,481
Boards Moderated 2
Alias Born 11/16/07
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2018 4:14:20 PM
Traders News Issues Research on High Growth Canna and Pharma Stocks InvestorsHub NewsWire - 4/25/2018 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/16/2018 1:18:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2018 3:04:31 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/7/2018 4:59:15 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/11/2018 4:35:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/27/2017 3:08:40 PM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) Edgar (US Regulatory) - 11/13/2017 10:03:05 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2017 4:04:57 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/22/2017 6:02:17 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/11/2017 12:47:10 PM
Annual Report (10-k) Edgar (US Regulatory) - 9/11/2017 6:04:38 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/11/2017 6:04:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2017 6:27:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2017 6:24:45 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/8/2017 4:18:08 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:17:33 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:17:00 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:16:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/13/2017 4:04:10 PM
KarinCA Member Level  Thursday, 12/07/17 04:46:48 PM
Re: Williamsc post# 206795
Post # of 231595 
Aspire made it possible for the company to purchase the Brilacidin platform in addition to running clinical trials. That purchase was brilliant.

Also, management isn't selling, unless they have a deal with a bp we aren't aware of yet.








To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist